Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Teleconsultation for psychological support.
- Who it may be relevant to
- Registry conditions: Central Nervous System Cancer, Psychological Distress. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System Between the Announcement of the Diagnosis and the First Treatment
Overview
The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group). Participants will be randomized into two groups : * group A) intervention: usual care + nurse teleconsultation for psychological support * group B) control: usual care alone Enrolment = Day0 (D0) Participants will : * groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire) * Group A : D0+2/4 das : nursing teleconsultation for psychological support * Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion * Group A : D0+15days: semi-directive interview, at home, for voluntary patients.
Detailed description
The expected benefits are as follows:
For the patient :
* Reduction in pre-treatment psychological distress * Reduced pre-treatment anxiety and depression * Better understanding of disease and treatments * Better adherence to the care proposed in the treatment pathway * Reduced stress during first hospital treatment
For healthcare professionals :
* Early detection of psychological distress * Early detection of unmet needs and appropriate individualized responses * Establishment of a climate of trust between patient and caregiver * Improved professional practices
For the healthcare system :
* Lower healthcare costs (fewer anxiolytic treatments, etc.) * Therapy to be integrated into the treatment pathway of patients with central nervous system cancer * Reduced socio-territorial inequalities in healthcare provision
Interventions
- Other Teleconsultation for psychological support
Teleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice
Primary outcome measures
- Distress thermometer [Time frame: 10 days]
Eligibility criteria
Inclusion criteria
- aged 18 and over
- being treated for a primary malignant tumor of the central nervous system (positive biopsy)
- with a Mini-Mental State score greater than 24
- not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
- with a distress score above 3 on the Psychological Distress Thermometer
- have access to computer equipment equipped with a microphone and webcam (smartphone, computer)
- able to read, write and speak French
- have given free and informed consent
- being affiliated to a social security scheme
Exclusion criteria
- with a history of psychiatric illness
- with recurrent cancer of the cerebral nervous system
- having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
- under guardianship, curatorship or deprived of liberty
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
France · 1 center
- University Hospital of Reunion Island - Neurosurgery department — Saint-Pierre-des-Corps
Identifiers
NCT: NCT06485310 · 2024/CHU/02